Ribovate Therapeutics Ribovate is developing the next generation targeted mRNA-lipid nanoparticle therapeutic platform. Startup Details Co-Founded by: Drew Weissman and Hamideh Parhiz Participates in PCI Ventures UPstart Recent News All PCI Ventures Posts Penn Startups Raising Capital – Spring 2022 Two Penn spinouts on the Technical.ly Philly RealLIST standout tech companies ExynAI has been shortlisted as a finalist for a SXSW Innovation Award Cogwear and Rezon to make brain enhancing wearable for athletes